Hibsago, the first FDA-approved antisense oligonucleotide to treat chronic hepatitis B, reduces the amount of virus and hepatitis B surface antigen in the body.

An Ebola outbreak has become the second-largest ever recorded, with thousands of deaths and infections spreading beyond the ...

Dengue fever has infected millions of people worldwide, and cases are now being acquired locally in parts of Europe. Although most patients recover, the disease has a dangerous characteristic: serious ...

I am currently hospitalized for a threatened miscarriage due to abdominal pain and bleeding at 13 weeks. Today is a record of ...

I started taking dienogest for the pain of endometriosis and adenomyosis. The pain has certainly eased, and my menstrual flow ...

The largest outbreak of epizootic hemorrhagic disease, or EHD, in Wisconsin history is being recorded in 2026 in southeastern counties. At least 2,305 white-tailed deer have been affected in at least ...

After decades of research, US scientists may finally be closing in on new ways to fight Alzheimer’s. But even the most ...

Don't ignore these warning signs. Here's how DVT blood clots happen and what to do if you have one.

GINATILAN’S African swine fever (ASF) outbreak is now considered contained after all 60 blood samples taken from pigs in the ...

In its own approval announcement on Oct. 20, the FDA hailed Hibsago as a “first-of-its-kind” treatment in chronic hepatitis B ...

FDA-approved Hibsago could help some adults with chronic hepatitis B stop antiviral therapy. Learn who qualifies, what trials found, and the key risks.

Nigeria intensifies Ebola surveillance after Abuja confirms imported case, with 44 contacts identified and Atiku questioning ...